Back

Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter defibrillator

3 April 2022 (17:32 - 17:40)
Organised by:
Congress Presentation Part of: News on ICDs Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Ian Crozier

Christchurch Hospital, Christchurch (New Zealand)

5 More presentations in this session

Presentation thumbnail
Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients. Insights from a multicenter registry
Doctor J. Luker (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Impact of generic ICD programming on clinical outcomes
Mrs P. Khan (London, GB)
Abstract Slides Video
Presentation thumbnail
S-ICD in heart failure patients: real-world data from a multicenter, european analysis
Doctor M. Schiavone (Milan, IT)
Abstract Slides Video
Presentation thumbnail
In-silico optimisation of ICD defibrillation efficacy by modifying lead/can configurations using a cohort of high-resolution whole-torso heart models
Doctor S. Qian (London, GB)
Abstract Slides Video
Presentation thumbnail
Delayed detection programming significantly reduces inappropriate ICD therapies in patients with left-ventricular assist devices.
Doctor S. Hohmann (Hildesheim, DE)
Abstract Slides Video

Access the full session

Session thumbnail
News on ICDs

The Event

Event poster

EHRA 2022

3 April 2022 17:32 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources